Table 1 Correlation between SPR expression and clinicopathological characteristics.

From: Sepiapterin reductase promotes hepatocellular carcinoma progression via FoxO3a/Bim signaling in a nonenzymatic manner

Variables

SPR expression

Total

χ2

p value

High

low

Age (year)

    

5.445

0.020

 

≤58

18

31

49

  
 

>58

29

19

48

  

T stage

    

5.461

0.019

 

T1/T2

24

37

61

  
 

T3/T4

23

13

36

  

TNM stage

    

5.461

0.019

 

Ι/II

24

37

61

  
 

III/IV

23

13

36

  

Sex

    

4.784

0.029

 

Female

3

11

14

  
 

Male

44

39

83

  

Cancer embolus

    

0.471

0.492

 

No

28

33

61

  
 

Yes

13

11

24

  
 

Null

12

    

Cirrhosis

    

0.008

0.927

 

No

10

11

21

  
 

Yes

33

38

71

  
 

Null

5

    

Grade

    

0.849

0.357

 

I/II

36

35

71

  
 

III

10

15

25

  
 

Null

  

1

  

CD34

     

0.493a

 

Negative

0

2

2

  
 

Positive

31

31

62

  
 

Null

  

33

  

CK19

    

0.042

0.838

 

Negative

32

35

67

  
 

Positive

15

15

30

  

Recurrence or metastasis

    

0.535

0.464

 

No

40

45

85

  
 

Yes

7

5

12

  
  1. TNM tumor node metastasis.
  2. aFisher exact probability test.
  3. Statistically significant values are shown in bold.